Tirzepatide – 60mg/vial · 10-Vial Pack (Research Use Only)
Availability: In stock
Availability: In stock
Research Disclaimer: All products currently listed on this site are for research purposes only.
Independent lab result · batch PTW-Tirz-2608-001
Tirzepatide 60mg. Tested by Janoshik Analytical (task #239838), analysis conducted 7 Oct 2026. The sample was pulled from our own stock, submitted and paid for by Portal to Wellness, and the report names us as the client.
- Identity: tirzepatide, confirmed by blind test
- Measured content: 65.05 mg per vial (labelled 60 mg)
- Purity: 99.740% (HPLC)
View and verify the full report on Janoshik’s site →
This result applies to batch PTW-Tirz-2608-001, the batch currently shipping. The batch number is printed on the vial label. See all published results on our Lab Testing & Verification page.
Overview
A ten-vial pack of research-grade Tirzepatide, 60mg per vial, supplied as a lyophilized powder. Tirzepatide is a synthetic dual GIP and GLP-1 receptor agonist peptide studied in the published literature for its interaction with incretin receptor signalling.
Supplied for laboratory and identification research purposes only. Not for human or veterinary use.
- Processing: Orders ship within 1–2 business days
- Domestic delivery: 3–5 business days via USPS Priority / UPS Ground
- Free shipping on orders over $100
- Temperature handling: Cold-chain packaging available on request for lyophilized peptides
- Tracking: Emailed automatically at time of dispatch
- Store lyophilized (dry) peptides at −4 °F for long-term stability
- Protect from light and moisture at all times
- Do not freeze
- Where the Storage row in the product specification above differs, follow the specification

Reviews
There are no reviews yet.